Hadrien Chef > Osborne Clarke > Brussels, Belgium > Lawyer Profile

Osborne Clarke
Marsveldplein 5
1050 Brussels
Belgium

Work Department

Corporate

Position

Partner, Belgium

Hadrien specialises in corporate and security law, corporate finance, mergers and acquisitions (M&A), venture capital, public offerings and corporate reorganisations. Hadrien also acts as a litigator in these matters and in market abuse disputes. Hadrien also assists in setting-up, reorganising, acquiring, or liquidating business ventures in Belgium.

Career

Prior to joining Osborne Clarke in 2016, Hadrien worked in the M&A Department of a leading Benelux firm. In 2014, Hadrien carried out a secondment at a leading global provider of specialised transportation and logistics. Hadrien also gained work experience as an Associate in Hong Kong in 2015.

Languages

Dutch, English, French, Italian

Education

Master’s Degree in Commercial Law and a Master’s Degree in Political Sciences from the Catholic University of Louvain and holds an LLM in International Law from the London School of Economics.

Lawyer Rankings

Belgium > Commercial, corporate and M&A

Osborne Clarke focuses on providing advice to clients in the life sciences, TMT, and retail sectors, with a capacity for handling a wide array of corporate governance, transactional, and commercial matters. David Haex is very active on mid-market M&A and venture capital transactions, while Stefan Deswert assists with a wide array of commercial agreements as well as carve-out matters with IP elements. Hadrien Chef, who stands out for providing corporate advice to biotech and medtech clients, is also highly recommended.

Belgium > Industry focus: Healthcare and life sciences

Rated by clients for the regulatory capabilities across the team, Osborne Clarke acts for a broad client base which notably includes Coopervision, OncoDNA, and Medi-market. The ‘excellentHadrien Chef leads the team and has vast corporate expertise, regularly assisting medical diagnostic, medtech, and biotech companies with financings and reorganisations. Praised for his ‘sharp edge‘, Vladimir Murovec is known for his deep regulatory knowledge, particularly in relation to digital health, pharma, and medical device issues.